Research Article
DNAJC3-AS1 Is Associated with Proliferation, Metastasis, and Poor Prognosis of Breast Cancer
Table 1
The correlations between DNAJC3-AS1 expression and clinicopathological factors of BC patients.
| | Characteristics | | DNAJC3-AS1 expression | | | High | Low |
| | Age (years) | | | | 0.775 | | ≤50 | 81 | 41 | 40 | | | >50 | 89 | 47 | 42 | | | Tumor size (cm) | | | | 0.259 | | ≤2 | 94 | 45 | 49 | | | >2 | 76 | 43 | 33 | | | Differentiation grade | | | | 0.950 | | | 102 | 53 | 49 | | | G3 | 68 | 35 | 33 | | | Histological type | | | | 0.493 | | Ductal | 97 | 48 | 49 | | | Lobular | 73 | 40 | 33 | | | ER status | | | | 0.609 | | Negative | 94 | 47 | 47 | | | Positive | 76 | 41 | 35 | | | PR status | | | | 0.150 | | Negative | 94 | 44 | 50 | | | Positive | 76 | 44 | 32 | | | HER-2 status | | | | 0.397 | | Negative | 98 | 48 | 50 | | | Positive | 72 | 40 | 32 | | | Lymph node metastasis | | | | 0.010 | | Absent | 112 | 50 | 62 | | | Present | 58 | 38 | 20 | | | Clinical stage | | | | 0.023 | | | 101 | 45 | 56 | | | III | 69 | 43 | 26 | |
|
|